acetylcysteine has been researched along with fps-zm1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| May, JM; Meredith, ME; Qu, ZC | 1 |
| Cai, L; Chen, XX; Keller, BB; Lin, Q; Tan, Y; Wang, X; Yu, HT; Zheng, Y | 1 |
2 other study(ies) available for acetylcysteine and fps-zm1
| Article | Year |
|---|---|
Ascorbate reverses high glucose- and RAGE-induced leak of the endothelial permeability barrier.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Benzamides; Cell Line; Cell Membrane Permeability; Cells, Cultured; Chromans; Cyclic N-Oxides; Dithiothreitol; Dose-Response Relationship, Drug; Endothelial Cells; Glucose; Glycation End Products, Advanced; HMGB1 Protein; Human Umbilical Vein Endothelial Cells; Humans; Mice; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Serum Albumin, Bovine; Spin Labels | 2014 |
Engineered cardiac tissues: a novel in vitro model to investigate the pathophysiology of mouse diabetic cardiomyopathy.
Topics: Acetylcysteine; Animals; Benzamides; Cells, Cultured; Diabetic Cardiomyopathies; Glycation End Products, Advanced; Inflammation; Mice; Myocardium; Myocytes, Cardiac; Oxidative Stress; Receptor for Advanced Glycation End Products; Tissue Engineering | 2021 |